Teckro, a Limerick, Ireland-based healthcare startup, raised $25m (£19.5m) in Series C funding.
The round, which brought total funding raised to date to $43m, was led by Northpond Ventures, Founders Fund, Sands Capital Ventures, Section 32, and Borealis Ventures.
The company intends to use the funds to double its workforce to continue to develop its platform.
Founded in 2015 led by CEO Gary Hughes, his brother Nigel Hughes, and Jacek Skrzypiec, Teckro uses machine learning speed up clinical trials by making it possible for all relevant information to be instantly accessible to every active member of a trial and for the entire study teams to be connected.
This means drugs and treatments for complex diseases are being developed quicker.
Over 10,000 users at pharmaceutical and biotech companies from over 80 countries are now using the platform.
The company also has offices Dublin and Nashville.